Lauren Lakdawala, PharmD, BCACP: American College of Clinical Pharmacy (ACCP): Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, July 15, 2021); Maryland Pharmacists Association: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, June 5, 2022)
June of 2015 marked the institution of the Content and Format of Labeling for Human Prescription Drug and Biological Products: Requirements for Pregnancy and Lactation Labeling Rule (PLLR). The PLLR marked the start to the phasing out of ABCD and X pregnancy categories and replacement with a description of potential risks. Due to this transition, it is necessary for pharmacists to be well versed in both systems to be able to communicate effectively with their medical colleagues. In this exciting session, find out how to most effectively navigate the PLLR to inform medication management decisions while managing communication with other healthcare professionals.
Learning Objectives:
Compare and contrast the pregnancy risk letter categories with the PLLR.
Accurately summarize guidance surrounding medication management in pregnancy, lactation, and patients of reproductive potential.
Recognize common drug-pregnancy consideration and articulate how to adjust medications for the most commonly prescribed medications.